A novel, non-opioid, selective orexin-1 receptor antagonist for the treatment of substance use disorders-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A novel, non-opioid, selective orexin-1 receptor antagonist for the treatment of substance use disorders

Published:2024 Issue: Volume:3 Page:104053
ISSN:2772-4085
Container-title:Neuroscience Applied
language:en
Short-container-title:Neuroscience Applied

Author:

Murray Clare M.,Fox J. Craig^ORCID,Heidbreder Christian^ORCID,Young Malcolm

Funder

NIDA

Publisher

Elsevier BV

Reference71 articles.

1. Provisional Drug Overdose Death Counts. National Center for Health Statistics;Ahmad,2023

2. The selective orexin 1 receptor antagonist SB-334867-A impairs acquisition and consolidation but not retrieval of spatial memory in Morris water maze;Akbari;Peptides,2007

3. Adolescent alcohol exposure increases orexin-A/hypocretin-1 in the anterior hypothalamus;Amodeo;Alcohol,2020

4. Changes in the gene expression and enzyme activity of hepatic cytochrome P450 in juvenile sprague-dawley rats;Asaoka;J. Vet. Med. Sci.,2010

5. Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats;Azizi;Neurosci. Lett.,2010

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP